The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10X Genomics Inc | CL A Common | 88025U109 | 2,154 | 14,798 | SH | SOLE | 14,798 | 0 | 0 | ||
Aadi Bioscience Inc | Common | 00032Q104 | 41,917 | 1,427,213 | SH | SOLE | 1,427,213 | 0 | 0 | ||
Aclaris Therapeutics, Inc. | Common | 00461U105 | 16,934 | 940,754 | SH | SOLE | 940,754 | 0 | 0 | ||
Aligos Therapeutics Inc | Common | 01626L105 | 55,014 | 3,547,030 | SH | SOLE | 3,547,030 | 0 | 0 | ||
ALX Oncology Holdings Inc | Common | 00166B105 | 311,693 | 4,220,048 | SH | SOLE | 4,220,048 | 0 | 0 | ||
Amyris, Inc | Common | 03236M200 | 159,847 | 11,642,195 | SH | SOLE | 11,642,195 | 0 | 0 | ||
Arcutis Biotherapeutics Inc | Common | 03969K108 | 10,358 | 433,585 | SH | SOLE | 433,585 | 0 | 0 | ||
Arrowhead Pharmaceuticals Inc | Common | 04280A100 | 8,579 | 137,411 | SH | SOLE | 137,411 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 121,233 | 760,606 | SH | SOLE | 760,606 | 0 | 0 | ||
Aslan Pharmaceuticals Ltd | ADS | 04522R101 | 5,057 | 2,840,909 | SH | SOLE | 2,840,909 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 11,081 | 500,732 | SH | SOLE | 500,732 | 0 | 0 | ||
Avadel Pharmaceuticals PLC | ADR | 05337M104 | 28,784 | 2,937,093 | SH | SOLE | 2,937,093 | 0 | 0 | ||
Bolt Therapeutics Inc | Common | 097702104 | 48,972 | 3,871,291 | SH | SOLE | 3,871,291 | 0 | 0 | ||
Celldex Therapeutics Inc | Common | 15117B202 | 26,156 | 484,453 | SH | SOLE | 484,453 | 0 | 0 | ||
Chinook Therapeutics Inc | Common | 16961L106 | 11,129 | 872,151 | SH | SOLE | 872,151 | 0 | 0 | ||
Codexis, Inc | Common | 192005106 | 9,028 | 388,144 | SH | SOLE | 388,144 | 0 | 0 | ||
Cogent Biosciences Inc | Common | 19240Q201 | 11,950 | 1,420,941 | SH | SOLE | 1,420,941 | 0 | 0 | ||
Crinetics Pharmaceuticals Inc | Common | 22663K107 | 10,889 | 517,280 | SH | SOLE | 517,280 | 0 | 0 | ||
Curis Inc | Common | 231269200 | 12,164 | 1,553,500 | SH | SOLE | 1,553,500 | 0 | 0 | ||
Design Therapeutics | Common | 25056L103 | 7,800 | 530,991 | SH | SOLE | 530,991 | 0 | 0 | ||
Dice Therapeutics Inc | Common | 23345J104 | 13,428 | 410,000 | SH | SOLE | 410,000 | 0 | 0 | ||
Dyne Therapeutics Inc | Common | 26818M108 | 9,381 | 577,642 | SH | SOLE | 577,642 | 0 | 0 | ||
Eiger BioPharmaceuticals Inc | Common | 28249U105 | 3,137 | 469,588 | SH | SOLE | 469,588 | 0 | 0 | ||
Elevation Oncology Inc | Common | 28623U101 | 3,870 | 496,843 | SH | SOLE | 496,843 | 0 | 0 | ||
Essa Pharma Inc | Common | 29668H708 | 8,449 | 1,056,067 | SH | SOLE | 1,056,067 | 0 | 0 | ||
Genetron Holdings Ltd | ADS | 37186H100 | 87,807 | 6,339,860 | SH | SOLE | 6,339,860 | 0 | 0 | ||
Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | 13,334 | 961,359 | SH | SOLE | 961,359 | 0 | 0 | ||
Harmony Biosciences Holdings Inc | Common | 413197104 | 187,217 | 4,884,341 | SH | SOLE | 4,884,341 | 0 | 0 | ||
Homology Medicines, Inc. | Common | 438083107 | 6,714 | 853,143 | SH | SOLE | 853,143 | 0 | 0 | ||
Impel NeuroPharma Inc | Common | 45258K109 | 35,137 | 2,884,789 | SH | SOLE | 2,884,789 | 0 | 0 | ||
Instil Bio Inc | Common | 45783C101 | 223,201 | 12,486,787 | SH | SOLE | 12,486,787 | 0 | 0 | ||
Iveric Bio Inc | Common | 46583P102 | 96,896 | 5,966,527 | SH | SOLE | 5,966,527 | 0 | 0 | ||
Kadmon Holdings Inc | Common | 48283N106 | 37,305 | 4,283,014 | SH | SOLE | 4,283,014 | 0 | 0 | ||
KalVista Pharmaceuticals Inc. | Common | 483497103 | 28,651 | 1,641,913 | SH | SOLE | 1,641,913 | 0 | 0 | ||
Kura Oncology Inc | Common | 50127T109 | 9,838 | 525,262 | SH | SOLE | 525,262 | 0 | 0 | ||
Larimar Therapeutics Inc | Common | 517125100 | 4,610 | 399,830 | SH | SOLE | 399,830 | 0 | 0 | ||
Legend Biotech Corp Sponsored | SPONSORED ADS | 52490G102 | 24,711 | 488,751 | SH | SOLE | 488,751 | 0 | 0 | ||
Mereo Biopharma Group PLC | ADS | 589492107 | 16,715 | 6,907,189 | SH | SOLE | 6,907,189 | 0 | 0 | ||
Merus NV | Common | N5749R100 | 9,724 | 442,000 | SH | SOLE | 442,000 | 0 | 0 | ||
Metacrine Inc | Common | 59101E103 | 502 | 146,426 | SH | SOLE | 146,426 | 0 | 0 | ||
New Frontier Health Corp | Ord Shs | G6461G106 | 160,589 | 14,300,000 | SH | SOLE | 14,300,000 | 0 | 0 | ||
Nkarta Inc | Common | 65487U108 | 14,245 | 512,225 | SH | SOLE | 512,225 | 0 | 0 | ||
Olema Pharmaceuticals Inc | Common | 68062P106 | 34,135 | 1,238,575 | SH | SOLE | 1,238,575 | 0 | 0 | ||
Orchard Therapeutics plc | ADS | 68570P101 | 3,049 | 1,325,736 | SH | SOLE | 1,325,736 | 0 | 0 | ||
Passage Bio Inc | Common | 702712100 | 5,371 | 539,263 | SH | SOLE | 539,263 | 0 | 0 | ||
Precision Biosciences Inc | Common | 74019P108 | 1,619 | 140,255 | SH | SOLE | 140,255 | 0 | 0 | ||
Satsuma Pharmaceuticals Inc | Common | 80405P107 | 5,743 | 1,232,394 | SH | SOLE | 1,232,394 | 0 | 0 | ||
Sera Prognostics Inc | Common | 81749D107 | 20,620 | 1,856,011 | SH | SOLE | 1,856,011 | 0 | 0 | ||
Sierra Oncology, Inc | Common | 82640U404 | 42,022 | 1,917,074 | SH | SOLE | 1,917,074 | 0 | 0 | ||
Sinovac Biotech Ltd. | SHS | P8696W104 | 38,173 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | ||
Syndax Pharmaceuticals Inc | Common | 87164F105 | 6,115 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
Tarsus Pharmaceuticals Inc | Common | 87650L103 | 64,377 | 2,987,331 | SH | SOLE | 2,987,331 | 0 | 0 | ||
Terns Pharmaceuticals Inc | Common | 880881107 | 27,875 | 2,675,133 | SH | SOLE | 2,675,133 | 0 | 0 | ||
Tricida, Inc. | Common | 89610F101 | 779 | 167,863 | SH | SOLE | 167,863 | 0 | 0 | ||
Valneva SE | SPONSORED ADS | 92025Y103 | 6,280 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Verona Pharma PLC | ADS | 925050106 | 15,070 | 2,749,918 | SH | SOLE | 2,749,918 | 0 | 0 | ||
Viridian Therapeutics Inc | Common | 92790C104 | 21,385 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
Zai Lab Ltd ADR | ADR | 98887Q104 | 18,443 | 174,999 | SH | SOLE | 174,999 | 0 | 0 | ||
Zogenix Inc | Common | 98978L204 | 1,595 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
Zymeworks Inc | Common | 98985W102 | 8,307 | 286,064 | SH | SOLE | 286,064 | 0 | 0 |